Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02681614 · ClinicalTrials.gov registry record · NA
Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT02681614: Completed NA study, sponsored by Case Comprehensive Cancer Center.
NCT02681614 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02681614, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This clinical research study tests the Uronav system. Patients with prostate cancer will be asked to take part in this study. Uronav system is an investigational device that is used on this study to help place markers in the patient. These are called fiducial markers and they are placed in the patient to help plan radiation treatment. Radiation therapy treatment will be planned by the treating physician and will not be experimental or part of this research study. This study will also test the similarities and differences of biopsy tissue structures and the findings from the intraprostatic MRI (internally guided MRI).
Primary Outcome
Number of participants who had biopsies with true positives between biopsy tissue and intraprostatic MRI (sensitivity of the intraprostatic MRI)
Interventions
- DEVICE Magnetic resonance imaging
- DEVICE Uronav guided biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2016-07-21 |
| Est. Completion | 2018-02-11 |
| Phase | NA |
What the finished NCT02681614 record still lists
NCT02681614 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Magnetic resonance imaging is the first listed.
NCT02681614 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02681614 about?
NCT02681614 is a clinical study titled "Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning". This clinical research study tests the Uronav system. Patients with prostate cancer will be asked to take part in this study. Uronav system is an investigational device that is used on this study to help place markers in the patient. These are called fiducial markers and they are placed in the pati...
What is the current status of trial NCT02681614?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2016-07-21. Estimated completion is 2018-02-11.
What interventions are being tested in trial NCT02681614?
The interventions under investigation include: Magnetic resonance imaging (DEVICE), Uronav guided biopsy (DEVICE).
Who is sponsoring clinical trial NCT02681614?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02681614's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI